ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseNicoletta Colombo, Ignace Vergote, Thaïs Baert et al.|Annals of Oncology|2019Cited by 1.2k
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, Andreas du Bois, François Planchamp et al.|International Journal of Gynecological Cancer|2016Cited by 141
Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast CancerStephen Chan, P. Fumoleau, Gilles Romieu et al.|Journal of Clinical Oncology|2009Cited by 119
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter StudyLucas Minig, Christina Fotopoulou, Florian Heitz et al.|Annals of Surgical Oncology|2017Cited by 54
Combining conventional therapy with immunotherapy: A risky business?An Coosemans, Ignace Vergote, Ann Vankerckhoven et al.|European Journal of Cancer|2019Cited by 31